RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA - Calimeri, T.; Cwynarski, K.; Pulczynski, E.; Fox, C. P.; Schorb, E.; Steffanoni, S.; Foppoli, M.; Celico, C.; Falautano, M.; Nonis, A.; La Rosee, P.; Binder, M.; et al. (HAEMATOLOGICA, 2021)
CRIS-Team WoS Importer:2021-12-03